Atlantic Healthcare completes patient enrollment to its Phase 3 study of alicaforsen to treat IBD Pouchitis
May 02, 2018 08:00 ET | Atlantic Healthcare plc
Study completion and top-line data expected in Q1 2019 CAMBRIDGE, U.K., May 02, 2018 (GLOBE NEWSWIRE) -- Atlantic Healthcare plc (Atlantic Healthcare), an emerging trans-Atlantic pharmaceutical...
Lyfebulb and UnitedHealth Group Announce an Innovation Challenge for Patient Entrepreneurs with Inflammatory Bowel Disease
April 23, 2018 15:18 ET | Lyfebulb; UnitedHealth Group
MINNETONKA, Minn. and NEW YORK, April 23, 2018 (GLOBE NEWSWIRE) -- Lyfebulb LLC and UnitedHealth Group (NYSE:UNH) invite patient entrepreneurs to compete in “Empowering Patients: An Innovation...
Metacrine Broadens Management Team with Two Key Hires
April 17, 2018 08:00 ET | Metacrine
SAN DIEGO, April 17, 2018 (GLOBE NEWSWIRE) -- Metacrine, Inc., an innovative biotechnology company developing therapies to benefit patients with liver, gastrointestinal and metabolic diseases, today...
Regentys, Cook Biotech to Collaborate in Developing, Delivering Unique Ulcerative Colitis Treatment
February 14, 2018 07:00 ET | Regentys
MIAMI LAKES, Fla., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Regentys (formerly Asana Medical, Inc.), a regenerative medicine company, today announced it will partner with Cook Biotech Inc., a world leader...
Lyfebulb Partners with UnitedHealth Group to Support Patient-Driven Innovations for People with Inflammatory Bowel Disease
January 17, 2018 08:00 ET | Lyfebulb
NEW YORK, Jan. 17, 2018 (GLOBE NEWSWIRE) -- Lyfebulb, a chronic disease-focused, patient-empowerment platform that connects patients, industry and investors to support user-driven innovation, is...
Regentys Names Dr. John F. Howes Vice President of Clinical and Regulatory Affairs
January 09, 2018 07:30 ET | Regentys
MIAMI LAKES, Fla., Jan. 09, 2018 (GLOBE NEWSWIRE) -- Regentys (formerly Asana Medical, Inc.) (the “Company”), a regenerative medicine company developing a novel treatment for Ulcerative Colitis...
Thetis Builds Scientific Advisory Board to Guide Development of Immuno-Resolving Therapies for IBD
December 11, 2017 10:35 ET | Thetis Pharmaceuticals LLC
BRANFORD, Conn., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Thetis Pharmaceuticals LLC (“Thetis”), a biopharmaceutical company developing oral, “immuno-resolving” therapies to treat inflammatory bowel...
Thetis Pharmaceuticals Awarded $2.3 Million Fast-Track NIH Grant to Develop Immuno-Resolving Therapy for Inflammatory Bowel Disease
November 16, 2017 12:35 ET | Thetis Pharmaceuticals LLC
BRANFORD, Conn., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Thetis Pharmaceuticals, a biopharmaceutical company developing “immuno-resolving” therapies for treatment of inflammatory bowel disease (IBD),...
Atlantic Healthcare develops tablet formulations of alicaforsen to treat Crohn's disease and Ulcerative Colitis
May 30, 2017 08:00 ET | Atlantic Healthcare plc
CAMBRIDGE, U.K., May 30, 2017 (GLOBE NEWSWIRE) -- Atlantic Healthcare plc (“Atlantic Healthcare”), an emerging trans-Atlantic pharmaceutical company with a core focus on gastrointestinal (GI)...
Patient Advocate Foundation logo
Jennifer Jaff Center Merges with Patient Advocate Foundation
May 02, 2016 09:14 ET | Patient Advocate Foundation
HAMPTON, Va., May 2, 2016 (GLOBE NEWSWIRE) -- The Jennifer Jaff Center, a respected national nonprofit for those suffering from chronic illness, has partnered with Patient Advocate Foundation to...